V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220016845 | 220013857 | 1.52 | 69.5 | Curative (C) | 2016-02-19 | 2016-04-29 | Cytarabine Low Dose | N | N | 220026839 | CYTARABINE |
| 220016848 | 220007009 | null | 75 | Curative (C) | 2017-10-15 | 2017-10-15 | CYTARABINE | N | N | 220026878 | CYTARABINE |
| 220016850 | 220007014 | 0 | null | Palliative (P) | 2016-09-23 | 2017-06-28 | Hydroxycarbamide | 02 | N | 220026886 | HYDROXYCARBAMIDE |
| 220016851 | 220007016 | null | 52 | Curative (C) | 2016-08-08 | 2016-10-21 | AML MyeChild | N | N | 220026891 | NOT MATCHED |
| 220016852 | 220007017 | 1.64 | 22.7 | Palliative (P) | 2013-05-21 | 2013-05-21 | AML Interim Guidelines FLA -Ida | N | N | 220026891 | NOT MATCHED |
| 220016853 | 220007018 | 1.73 | null | Curative (C) | 2017-09-26 | 2017-10-17 | Hydroxycarbamide | 02 | N | 220026893 | HYDROXYCARBAMIDE |
| 220016854 | 220007019 | null | 97 | Curative (C) | 2016-08-25 | 2016-08-28 | Cytarabine low (10to20mg/m2) IV/SC | Y | N | 220026895 | CYTARABINE |
| 220016855 | 220013865 | 1.73 | 18.9 | Curative (C) | null | 2017-04-09 | null | N | N | 220026899 | NOT MATCHED |
| 220016856 | 220007023 | 1.63 | null | Curative (C) | 2015-07-25 | 2015-10-05 | Cytarabine low (10to20mg/m2) IV/SC | 1 | N | 220026922 | CYTARABINE |
| 220016857 | 220007024 | null | 57.2 | Curative (C) | 2016-01-14 | 2016-04-10 | Cytarabine low (10to20mg/m2) IV/SC | 1 | N | 220026923 | CYTARABINE |
| 220016858 | 220007025 | 1.15 | 78 | Curative (C) | 2016-09-17 | 2016-09-22 | BMT Fludarabine/Thiotepa/Treosulfan + ATG | N | N | 220026928 | NOT MATCHED |
| 220016859 | 220013871 | null | 66.7 | Curative (C) | 2018-05-24 | 2018-10-14 | Cytarabine Low Dose | 2 | N | 220026936 | CYTARABINE |
| 220016861 | 220007029 | 1.67 | null | Disease modification (D) | 2017-01-04 | 2017-02-17 | Cytarabine Low Dose | 2 | N | 220026950 | CYTARABINE |
| 220016862 | 220013873 | null | 60.5 | Palliative (P) | 2015-03-04 | 2017-11-13 | Cytarabine low (10to20mg/m2) IV/SC | 02 | N | 220026951 | CYTARABINE |
| 220016863 | 220007032 | null | 62 | Adjuvant (A) | 2017-09-10 | 2017-09-11 | CYTARABINE | 02 | N | 220026952 | CYTARABINE |
| 220016864 | 220007034 | null | null | Palliative (P) | 2017-01-31 | 2017-02-06 | AML MyeChild 01 IT Cyt | N | N | 220026961 | NOT MATCHED |
| 220016865 | 220013875 | null | 88.7 | Curative (C) | 2015-11-14 | 2015-11-14 | CYTARABINE | N | N | 220026962 | CYTARABINE |
| 220016866 | 220013876 | 0 | 76.5 | Palliative (P) | 2013-10-18 | 2013-10-18 | Hydroxycarbamide | 2 | N | 220026963 | HYDROXYCARBAMIDE |
| 220016867 | 220007042 | 1.71 | 0 | Palliative (P) | 2015-02-03 | 2015-02-03 | Hydroxycarbamide | null | null | 220026967 | HYDROXYCARBAMIDE |
| 220016868 | 220007044 | 1.08 | 50.9 | null | null | 2015-12-15 | Amsacrine + ANTITHYMOCYTE IMMUNOGLOBULIN (RABBIT) + CYCLOPHOSPHAMIDE + CYTARABINE + FLUDARABINE | 2 | N | 220026968 | NOT MATCHED |
| 220016869 | 220007045 | null | 85.5 | Palliative (P) | 2019-01-14 | 2019-01-15 | Hydroxycarbamide | 02 | N | 220026971 | HYDROXYCARBAMIDE |
| 220016871 | 220007052 | 1.72 | 85 | Palliative (P) | null | 2016-11-09 | Hydroxycarbamide | N | 2 | 220026981 | HYDROXYCARBAMIDE |
| 220016872 | 220007054 | null | null | Curative (C) | 2016-12-28 | 2017-06-08 | Cytarabine Low Dose | N | N | 220027011 | CYTARABINE |
| 220016873 | 220007055 | null | 59.9 | Disease modification (D) | 2014-08-04 | 2014-09-07 | Hydroxycarbamide | N | null | 220027014 | HYDROXYCARBAMIDE |
| 220016874 | 220007058 | 1.67 | 109 | Adjuvant (A) | 2018-08-24 | 2018-08-24 | FLUDARABINE + THIOTEPA + TREOSULFAN | N | N | 220027025 | NOT MATCHED |
| 220016875 | 220007063 | 1.62 | 108.4 | Disease modification (D) | 2017-11-30 | 2017-12-02 | CYTARABINE | 02 | N | 220027033 | CYTARABINE |
| 220016876 | 220007064 | 0 | null | Palliative (P) | 2017-12-13 | 2017-12-15 | Hydroxycarbamide | 99 | N | 220027042 | HYDROXYCARBAMIDE |
| 220016877 | 220007067 | 1.83 | null | Palliative (P) | 2015-10-12 | 2015-10-13 | Hydroxycarbamide | 2 | N | 220027042 | HYDROXYCARBAMIDE |
| 220016878 | 220007067 | 1.81 | 94.6 | Curative (C) | 2016-12-29 | 2017-02-09 | AML Relapsed High Dose Cytarabine | Y | N | 220027042 | NOT MATCHED |
| 220016879 | 220007068 | 0 | 21.5 | Curative (C) | 2013-07-30 | 2013-10-04 | null | 2 | N | 220027059 | NOT MATCHED |
| 220016880 | 220007068 | null | 90 | Palliative (P) | 2017-05-08 | 2017-05-12 | Cytarabine Low Dose | N | N | 220027059 | CYTARABINE |
| 220016881 | 220007069 | 1.55 | null | Palliative (P) | 2018-01-23 | 2018-01-24 | Cytarabine Intrathecal (any age) | 02 | N | 220027071 | CYTARABINE |
| 220016882 | 220007071 | null | 30.6 | Curative (C) | 2015-12-05 | 2015-12-05 | AML MyeChild 01 Triple IT | N | null | 220027077 | NOT MATCHED |
| 220016883 | 220007073 | null | 51 | null | null | 2013-08-15 | CYTARABINE | N | null | 220027087 | CYTARABINE |
| 220016884 | 220007074 | 1.61 | 56.8 | Palliative (P) | null | 2018-02-04 | Hydroxycarbamide | 02 | N | 220027108 | HYDROXYCARBAMIDE |
| 220016885 | 220019621 | 0 | 11.5 | Curative (C) | 2016-07-30 | 2016-10-26 | AML MyeChild 01 Triple IT | 02 | N | 220027115 | NOT MATCHED |
| 220016886 | 220007076 | 1.52 | null | null | 2017-03-17 | 2017-03-20 | CYTARABINE | 2 | N | 220027129 | CYTARABINE |
| 220016887 | 220007077 | 0 | 37.05 | Disease modification (D) | 2017-11-23 | 2018-02-16 | AML MyeChild 01 HD AraC | 02 | N | 220027135 | NOT MATCHED |
| 220016888 | 220013900 | 1.66 | 82.6 | Disease modification (D) | 2015-02-20 | 2015-06-07 | Hydroxycarbamide | 01 | N | 220027142 | HYDROXYCARBAMIDE |
| 220016889 | 220007079 | null | 60.5 | null | 2016-07-06 | 2016-07-06 | CYTARABINE | N | N | 220027145 | CYTARABINE |
| 220016890 | 220007082 | null | null | Palliative (P) | 2013-11-17 | 2013-11-19 | Hydroxycarbamide | 02 | N | 220027147 | HYDROXYCARBAMIDE |
| 220016891 | 220007084 | 1.66 | 84.7 | Curative (C) | 2017-08-16 | 2017-08-16 | Hydroxycarbamide | 2 | N | 220027157 | HYDROXYCARBAMIDE |
| 220016892 | 220013902 | 1.7 | 55.8 | Curative (C) | null | 2018-07-17 | CYTARABINE + FLUDARABINE + IDARUBICIN + Tretinoin Gemtuzumab Ozogamicin | N | null | 220027160 | NOT MATCHED |
| 220016893 | 220017566 | null | 61 | Curative (C) | 2016-05-13 | 2016-05-13 | FLUDARABINE + THIOTEPA + TREOSULFAN | 2 | Y | 220027170 | NOT MATCHED |
| 220016894 | 220007088 | 1.81 | null | Curative (C) | 2016-09-14 | 2016-09-15 | APML Consolidation I ATRA,Cytarabine,Mitoxantrone | 02 | N | 220027179 | NOT MATCHED |
| 220016895 | 220007092 | null | 58.6 | Not known (9) | 2015-04-22 | 2015-04-25 | Cytarabine Low Dose | N | N | 220027188 | CYTARABINE |
| 220016896 | 220007095 | 1.64 | 45 | Curative (C) | null | 2014-02-23 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220027205 | CYTARABINE |
| 220016897 | 220021488 | 0 | 15.1 | Disease modification (D) | 2014-06-05 | 2014-06-12 | Cytarabine Low Dose | 02 | N | 220027215 | CYTARABINE |
| 220016898 | 220021488 | 0 | 38.4 | Disease modification (D) | 2014-01-08 | 2014-01-09 | AML MyeChild 01 B Cytarabine/Daunoxome | 02 | N | 220027215 | NOT MATCHED |
| 220016899 | 220007097 | null | null | Palliative (P) | 2016-03-28 | 2016-03-31 | Hydroxycarbamide | 01 | N | 220027219 | HYDROXYCARBAMIDE |